pHion Therapeutics Ltd.

Recent Finacing

Equity

Recent Raise

Undisclosed

pHion Therapeutics develops mRNA/saRNA vaccines using its 30-amino-acid RALA peptide to form nanoparticles enabling room-temperature-stable delivery, with a Belfast mRNA production lab and preclinical oncology programs.

Founded 2017

Belfast, United Kingdom

11-50

Private

phiontx.co.uk

Highlights

Focus Areas

Biotechnology

Recent Investors

Financials

1

Funding round

1

Investor

Team

Upgrade to view the team

See the team members at pHion Therapeutics Ltd..